1. Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study. Issue 1 (January 2017) Authors: Passamonti, Francesco; Griesshammer, Martin; Palandri, Francesca; Egyed, Miklos; Benevolo, Giulia; Devos, Timothy; Callum, Jeannie; Vannucchi, Alessandro M; Sivgin, Serdar; Bensasson, Caroline; Khan, Mahmudul; Mounedji, Nadjat; Saydam, Guray Journal: Lancet oncology Issue: Volume 18:Issue 1(2017:Jan.) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study. Issue 3 (1st June 2020) Authors: Bachet, Jean-Baptiste; Wyrwicz, Lucjan; Price, Timothy; Cremolini, Chiara; Phelip, Jean-Marc; Portales, Fabienne; Ozet, Ahmet; Cicin, Irfan; Atlan, Dan; Becquart, Martin; Vidot, Loick; Mounedji, Nadjat; Van Cutsem, Eric; Taieb, Julien; Falcone, Alfredo Journal: ESMO open Issue: Volume 5:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗